BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 868984)

  • 1. Follow-up study in eyes with choroidal neovascularization caused by presumed ocular histoplasmosis.
    Klein ML; Fine SL; Knox DL; Patz A
    Am J Ophthalmol; 1977 Jun; 83(6):830-5. PubMed ID: 868984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.
    Berger AS; Conway M; Del Priore LV; Walker RS; Pollack JS; Kaplan HJ
    Arch Ophthalmol; 1997 Aug; 115(8):991-6. PubMed ID: 9258220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual results after surgical removal of subfoveal choroidal neovascular membranes.
    Thomas MA; Dickinson JD; Melberg NS; Ibanez HE; Dhaliwal RS
    Ophthalmology; 1994 Aug; 101(8):1384-96. PubMed ID: 7520148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9.
    Hawkins BS; Bressler NM; Bressler SB; Davidorf FH; Hoskins JC; Marsh MJ; Miskala PH; Redford M; Sternberg P; Thomas MA; Toth CA;
    Arch Ophthalmol; 2004 Nov; 122(11):1597-611. PubMed ID: 15534121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
    Atebara NH; Thomas MA; Holekamp NM; Mandell BA; Del Priore LV
    Ophthalmology; 1998 Sep; 105(9):1598-605. PubMed ID: 9754163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripapillary neovascular membranes in presumed ocular histoplasmosis.
    Cantrill HL; Burgess D
    Am J Ophthalmol; 1980 Feb; 89(2):192-203. PubMed ID: 6153509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of a long-standing subfoveal neovascular membrane secondary to ocular histoplasmosis.
    Wind BE; Sobol WM
    Ophthalmic Surg; 1993 Jan; 24(1):36-9. PubMed ID: 7680442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-beam irradiation of subfoveal choroidal neovascular membranes in presumed ocular histoplasmosis syndrome: a case report.
    Liem SE; Armbruster FC
    J Am Optom Assoc; 1998 Aug; 69(8):493-9. PubMed ID: 9747044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration.
    Fujii GY; Humayun MS; Pieramici DJ; Schachat AP; Au Eong KG; de Juan E
    Am J Ophthalmol; 2001 Jan; 131(1):90-100. PubMed ID: 11162983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of foveal pigment epithelial detachments with contiguous extrafoveal choroidal neovascular membranes.
    Maguire JI; Benson WE; Brown GC
    Am J Ophthalmol; 1990 May; 109(5):523-9. PubMed ID: 1692183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study.
    Kleiner RC; Ratner CM; Enger C; Fine SL
    Retina; 1988; 8(4):225-9. PubMed ID: 2466316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion of the subfoveal choriocapillaris affects visual recovery after submacular surgery in presumed ocular histoplasmosis syndrome.
    Akduman L; Del Priore LV; Desai VN; Olk RJ; Kaplan HJ
    Am J Ophthalmol; 1997 Jan; 123(1):90-6. PubMed ID: 9186102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes.
    Gass JD
    Am J Ophthalmol; 1994 Sep; 118(3):285-98. PubMed ID: 7521987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results.
    Berger AS; Kaplan HJ
    Ophthalmology; 1992 Jun; 99(6):969-75; discussion 975-6. PubMed ID: 1630786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foveal translocation: a comparison of two techniques.
    Ohji M; Fujikado T; Saito Y; Hosohata J; Hayashi A; Tano Y
    Semin Ophthalmol; 1998 Mar; 13(1):52-62. PubMed ID: 9567012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome.
    Melberg NS; Thomas MA; Burgess DB
    Retina; 1996; 16(3):190-5. PubMed ID: 8789856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.